Search Page

1

Cite

Share

Postdischarge venous thromboembolism following hospital admission with COVID-19.

Roberts LN, Whyte MB, Georgiou L, Giron G, Czuprynska J, Rea C, Vadher B, Patel RK, Gee E, Arya R. Roberts LN, et al. Among authors: whyte mb. Blood. 2020 Sep 10;136(11):1347-1350. doi: 10.1182/blood.2020008086. Blood. 2020. PMID: 32746455 Free PMC article.

Cite

Share

2

Cite

Share

Pulmonary embolism in hospitalised patients with COVID-19.

Whyte MB, Kelly PA, Gonzalez E, Arya R, Roberts LN. Whyte MB, et al. Thromb Res. 2020 Nov;195:95-99. doi: 10.1016/j.thromres.2020.07.025. Epub 2020 Jul 10. Thromb Res. 2020. PMID: 32682004 Free PMC article.

Cite

Share

3

Cite

Share

The use of GLP-1 receptor agonists in hospitalised patients: An untapped potential.

Mustafa OG, Whyte MB. Mustafa OG, et al. Among authors: whyte mb. Diabetes Metab Res Rev. 2019 Nov;35(8):e3191. doi: 10.1002/dmrr.3191. Epub 2019 Jun 28. Diabetes Metab Res Rev. 2019. PMID: 31141838 Free PMC article. Review.

Cite

Share

4

Cite

Share

Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study.

Woodmansey C, McGovern AP, McCullough KA, Whyte MB, Munro NM, Correa AC, Gatenby PAC, Jones SA, de Lusignan S. Woodmansey C, et al. Among authors: whyte mb. Diabetes Care. 2017 Nov;40(11):1486-1493. doi: 10.2337/dc17-0542. Epub 2017 Aug 31. Diabetes Care. 2017. PMID: 28860126

Cite

Share

5

Cite

Share

Laboratory tests seldom give certainty.

Whyte MB, Kelly P. Whyte MB, et al. BMJ. 2019 Apr 16;365:l1719. doi: 10.1136/bmj.l1719. BMJ. 2019. PMID: 30992259 No abstract available.

Cite

Share

6

Cite

Share

Adult height as a contributor to cardiometabolic risk.

Whyte MB. Whyte MB. Postgrad Med J. 2021 Mar;97(1145):202. doi: 10.1136/postgradmedj-2020-138164. Epub 2020 Jun 11. Postgrad Med J. 2021. PMID: 32527758 No abstract available.

Cite

Share

7

Cite

Share

'Working diagnosis' as a means to reduce cognitive bias.

Sullivan SJ, Whyte MB. Sullivan SJ, et al. Among authors: whyte mb. J R Coll Physicians Edinb. 2019 Jun;49(2):171-174. doi: 10.4997/JRCPE.2019.223. J R Coll Physicians Edinb. 2019. PMID: 31188356 No abstract available.

Cite

Share

8

Cite

Share

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.

Whyte MB, Shojaee-Moradie F, Sharaf SE, Jackson NC, Fielding B, Hovorka R, Mendis J, Russell-Jones D, Umpleby AM. Whyte MB, et al. J Clin Endocrinol Metab. 2019 Feb 1;104(2):359-368. doi: 10.1210/jc.2018-01176. J Clin Endocrinol Metab. 2019. PMID: 30215735 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?

Whyte MB. Whyte MB. JRSM Cardiovasc Dis. 2019 Aug 12;8:2048004019869736. doi: 10.1177/2048004019869736. eCollection 2019 Jan-Dec. JRSM Cardiovasc Dis. 2019. PMID: 31448115 Free PMC article. Review.

Cite

Share

10

Cite

Share

Greater illness severity characterises steroid diabetes following acute hospitalisation.

Abbas N, Elhassan M, Kelly P, Yorke R, Mustafa OG, Whyte MB. Abbas N, et al. Among authors: whyte mb. Clin Med (Lond). 2019 Jan;19(1):86-87. doi: 10.7861/clinmedicine.19-1-86. Clin Med (Lond). 2019. PMID: 30651256 Free PMC article. No abstract available.

Cite

Share